Multifactorial comparison of modified and conventional perfusion strategies in a porcine model of cardiopulmonary bypass.

[1]  S. Khuri,et al.  Evaluation of blood components exposed to coated arterial filters in extracorporeal circuits , 2009, Perfusion.

[2]  M. Diena,et al.  Reduced transfusion requirements with a closed cardiopulmonary bypass system. , 2008, The Journal of cardiovascular surgery.

[3]  Zhongqiu Wang,et al.  Hepatic injury in a rat cardiopulmonary bypass model. , 2008, Interactive cardiovascular and thoracic surgery.

[4]  S. Khuri,et al.  Nonsurgical bleeding diathesis in anemic thrombocytopenic patients: role of temperature, red blood cells, platelets, and plasma‐clotting proteins , 2007, Transfusion.

[5]  P. Sfirakis,et al.  Postoperative jaundice after cardiac surgery. , 2007, Hepatobiliary & pancreatic diseases international : HBPD INT.

[6]  M. Jessen.  Pro: Heparin-coated circuits should be used for cardiopulmonary bypass. , 2006, Anesthesia and analgesia.

[7]  V. Videm,et al.  Neutrophil dysfunction after biomaterial contact in an in vitro model of cardiopulmonary bypass. , 2006, European Journal of Cardio-Thoracic Surgery.

[8]  K. Mccusker,et al.  Influence of hematocrit and pump prime on cerebral oxygen saturation in on-pump coronary revascularization , 2006, Perfusion.

[9]  G. Angelini,et al.  Splanchnic organ injury during coronary surgery with or without cardiopulmonary bypass: a randomized, controlled trial. , 2006, The Annals of thoracic surgery.

[10]  Maria Cristina Tanzi,et al.  Bioactive technologies for hemocompatibility , 2005, Expert review of medical devices.

[11]  K M Taylor,et al.  The systemic inflammatory response syndrome and cardiopulmonary bypass. , 2005, International journal of surgery.

[12]  W. Saggau,et al.  Blood-Air Interface during Cardiopulmonary Bypass , 2004, Asian cardiovascular & thoracic annals.

[13]  C. Hack,et al.  The Impact of Heparin-Coated Cardiopulmonary Bypass Circuits on Pulmonary Function and the Release of Inflammatory Mediators , 2004, Anesthesia and analgesia.

[14]  S. D. Kim,et al.  The effect of bloodless pump prime on cerebral oxygenation in paediatric patients , 2004, Acta anaesthesiologica Scandinavica.

[15]  S. Andréasson,et al.  Changes in hemostasis during pediatric heart surgery: impact of a biocompatible heparin-coated perfusion system. , 2004, The Annals of thoracic surgery.

[16]  John D Lambris,et al.  Effect of complement inhibition and heparin coating on artificial surface-induced leukocyte and platelet activation. , 2004, The Annals of thoracic surgery.

[17]  J. Lundahl,et al.  Activation of complement and leukocyte receptors during on- and off pump coronary artery bypass surgery. , 2004, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[18]  John G. Laffey,et al.  The Systemic Inflammatory Response to Cardiac Surgery: Implications for the Anesthesiologist , 2002, Anesthesiology.

[19]  J. Levy,et al.  Aprotinin and the systemic inflammatory response after cardiopulmonary bypass. , 2001, The Annals of thoracic surgery.

[20]  H P Wendel,et al.  Coating-techniques to improve the hemocompatibility of artificial devices used for extracorporeal circulation. , 1999, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[21]  S. Khuri,et al.  Comparison of the effects of transfusions of cryopreserved and liquid-preserved platelets on hemostasis and blood loss after cardiopulmonary bypass. , 1999, The Journal of thoracic and cardiovascular surgery.

[22]  R. Shemin,et al.  Effect of anticoagulation protocol on outcome in patients undergoing CABG with heparin-bonded cardiopulmonary bypass circuits. , 1998, The Annals of thoracic surgery.

[23]  S. Bannan,et al.  Cell activation and thrombin generation in heparin bonded cardiopulmonary bypass circuits using a novel in vitro model. , 1997, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[24]  J. Loscalzo,et al.  Effect of heparin on fibrinolytic activity and platelet function in vivo. , 1996, The American journal of physiology.

[25]  J. Loscalzo,et al.  Heparin causes platelet dysfunction and induces fibrinolysis before cardiopulmonary bypass. , 1995, The Annals of thoracic surgery.

[26]  J. Loscalzo,et al.  Heparin Causes Platelet Dysfunction and Induces Fibrinolysis Before the Institution of Cardiopulmonary Bypass , 1995 .

[27]  P. Everts,et al.  Systemic blood activation with open and closed venous reservoirs. , 1995, The Annals of thoracic surgery.

[28]  R. Adamson,et al.  Effect of prophylactic epsilon-aminocaproic acid on blood loss and transfusion requirements in patients undergoing first-time coronary artery bypass grafting , 1994 .

[29]  R. Adamson,et al.  Effect of prophylactic epsilon-aminocaproic acid on blood loss and transfusion requirements in patients undergoing first-time coronary artery bypass grafting. A randomized, prospective, double-blind study. , 1994, The Journal of thoracic and cardiovascular surgery.

[30]  W. Baumgartner,et al.  Inhibition of neutrophil adhesion during cardiopulmonary bypass. , 1994, The Annals of thoracic surgery.

[31]  S. Khuri,et al.  Hematologic changes during and after cardiopulmonary bypass and their relationship to the bleeding time and nonsurgical blood loss. , 1992, The Journal of thoracic and cardiovascular surgery.

[32]  W. Baumgartner,et al.  Leukocyte depletion ameliorates free radical-mediated lung injury after cardiopulmonary bypass. , 1990, The Journal of thoracic and cardiovascular surgery.

[33]  E. Blackstone,et al.  Effects of protamine administration after cardiopulmonary bypass on complement, blood elements, and the hemodynamic state. , 1986, The Annals of thoracic surgery.

[34]  J. Kaneko.  Clinical biochemistry of domestic animals , 1963 .